Desmosomal adhesion and pemphigus vulgaris: The first half of the story

Cell Communication and Adhesion

Volumn 20, Issue 1-2, 2013, Pages 1-10

  Cirillo, Nicola ^a,b   Al Jandan, Badr A ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Cell adhesion; Desmosome; Dsg3; Keratinocytes; Pemphigus

Indexed keywords

DESMOGLEIN; IMMUNOGLOBULIN G; PROTEINASE;

ACANTHOLYSIS; CELL ADHESION; CELL FATE; CELL ISOLATION; CLONING; DESMOSOME; DOWN REGULATION; HUMAN; INTERNALIZATION; NONHUMAN; PATHOGENESIS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; STEREOSPECIFICITY; TRANSCRIPTION INITIATION; TRANSLATIONAL RESEARCH;

ACANTHOLYSIS; ANIMALS; AUTOANTIBODIES; CADHERINS; CELL ADHESION; CELL COMMUNICATION; CELLS, CULTURED; DESMOGLEIN 3; DESMOSOMES; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MICE; MICE, KNOCKOUT; PEMPHIGUS;

MUS;

EID: 84875948406     PISSN: 15419061     EISSN: 15435180     Source Type: Journal    
DOI: 10.3109/15419061.2013.763799     Document Type: Review

References (87)

1. Aho S (2004). Plakin proteins are coordinately cleaved during apoptosis but preferentially through the action of different caspases. Exp Dermatol. 13:700-707.
2. Amagai M, Klaus-Kovtun V, Stanley JR (1991). Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 67 : 869-877.
3. Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T (1999). The clinical phenotype of pemphigus is defi ned by the antidesmoglein autoantibody profi le. J Am Acad Dermatol. 40 : 167-170.
4. Amagai M (1999). Autoimmunity against desmosomalcadherins in pemphigus. J Dermatol Sci. 20 : 92-102.
5. Amagai M, Karpati S, Prussick R, Klaus-Kovtun V, Stanley JR (1992). Autoantibodiesagainst the amino-terminal cadherinlike binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest. 90 : 919-926.
6. Aoyama Y, Nagai M, Kitajima Y (2010). Binding of pemphigus vulgaris IgG to antigens in desmosome core domains excludes immune complexes rather than directly splitting desmosomes. Br J Dermatol. 162 : 1049-1055.
7. Aoyama Y, Kitajima Y (1999). Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3- depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J Invest Dermatol. 112 : 67-71.
8. Aoyama Y, Owada MK, Kitajima Y (1999). A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phos phorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur J Immunol. 29: 2233-2240.
9. Arredondo J, Chernyavsky AI, Karaouni A, Grando SA (2005). Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus. Am J Pathol. 167: 1531-1544.
10. Baroni A, Lanza A, Cirillo N, Brunetti G, Ruocco E, Ruocco V (2007). Vesicular and bullous disorders: pemphigus. Dermatol Clin. 25 : 597-603.
11. Berkowitz P, Hu P, Warren S, Liu Z, Diaz LA, Rubenstein DS (2006). p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci USA. 103 : 12855-12860.
12. Bhol K, Natarajan K, Nagarwalla N, Mohimen A, Aoki V, Ahmed AR (1995). Correlation of peptide specifi city and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci USA 92 : 5239-5243.
13. Bystryn JC, Rudolph JL (2005). Pemphigus. Lancet. 366 : 61-73.
14. Bystryn JC, Grando SA (2006). A novel explanation for acantholysis in pemphigus vulgaris: the basal cell shrinkage hypothesis. J Am Acad Dermatol. 54 : 513-516.
15. Cirillo N, Femiano F, Gombos F, Lanza A (2006). Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes. FEBS Lett. 580 : 3276-3281.
16. Cirillo N, Femiano F, Gombos F, Lanza A (2007a). Metalloproteinase 9 is the outer executioner of desmoglein 3 in apoptotic keratinocytes. Oral Dis. 13 : 341-345.
17. Cirillo N, Lanza M, Rossiello L, Gombos F, Lanza A (2007b). Defi ning the involvement of proteinases in pemphigus vulgaris: evidence of matrix metalloproteinase-9 overexpression in experimental models of disease. J Cell Physiol. 212 : 36-41.
18. Cirillo N, Gombos F, Ruocco V, Lanza A (2007c). Searching for experimental models of Pemphigus vulgaris. Arch Dermatol Res. 299 : 9-12.
19. Cirillo N, Dell ' Ermo A, Gombos F, Lanza A (2008a). The specifi c proteolysis hypothesis of pemphigus: does the song remain the same? Med Hypotheses. 70 : 333-337.
20. Cirillo N, Lanza M, De Rosa A, Cammarota M, La Gatta A, Gombos F, Lanza A (2008b). The most widespread desmosomal cadherin, desmoglein 2, is a novel target of caspase 3-mediated apoptotic machinery. J Cell Biochem. 103: 598-606.
21. Cirillo N, Campisi G, Gombos F, Perillo L, Femiano F, Lanza A (2008c). Cleavage of desmoglein 3 can explain its depletion from keratinocytes in pemphigus vulgaris. Exp Dermatol. 17 : 858-863.
22. Cirillo N, Lanza A, Gombos F (2009a). Pathophysiology of the Desmosome. Kerala, India: Research Signpost.
23. Cirillo N, Femiano F, Gombos F, Lanza A (2009b). High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes. Immunol Lett. 122 : 208-213
24. Cirillo N, Prime SS (2009). Desmosomal interactome in keratinocytes: a systems biology approach leading to an understanding of the pathogenesis of skin disease. Cell Mol Life Sci. 66 : 3517-3533.
25. Cirillo N, Lanza A, Prime SS (2010). Induction of hyperadhesion attenuates autoimmune-induced keratinocyte cellcell detachment and processing of adhesion molecules via mechanisms that involve PKC. Exp Cell Res. 316 : 580-592.
26. Cirillo N (2011). Techniques in Epidermal Biology: An Integrated Approach to Autoimmune Disease. New York: Nova Science Publishers Inc.
27. Cirillo N, Cozzani E, Carrozzo M, Grando S (2012). Urban legends: pemphigus vulgaris. Oral Dis. 18 : 442-458.
28. Cirillo N (2012). Merging experimental data and in silico analysis: a systems-level approach to autoimmune disease and cancer. Expert Rev Clin Immunol. 8 : 361-372.
29. Calkins CC, Setzer SV, Jennings JM, Summers S, Tsunoda K, Amagai M, Kowalczyk AP (2006). Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem. 281 : 7623-7634.
30. Chernyavsky AI, Arredondo J, Kitajima Y, Sato-Nagai M, Grando SA (2007). Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem. 282 : 13804-13812.
31. Chen J, Den Z, Koch PJ (2008). Loss of desmocollin 3 in mice leads to epidermal blistering. J Cell Sci. 121 : 2844-2849.
32. Delva E, Jennings JM, Calkins CC, Kottke MD, Faundez V, Kowalczyk AP (2008). Pemphigus vulgaris IgG-induced desmoglein3 endocytosis and desmosomal disassembly are mediated by a clathrin and dynamin-independent mechanism. J Biol Chem. 283 : 18303-18313.
33. Ding X, Aoki V, Mascar ò JM, Lopez-Swiderski A, Diaz LA, Fairley LA (1997). Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profi les. J Invest Dermatol. 109 : 592-596.
34. Dmochowski M, Hashimoto T, Garrod DR, Nishikawa T (1993). Desmocollins I and II are recognized by certain sera from patients with various types of pemphigus, particularly Brazilian pemphigus foliaceus. J Invest Dermatol. 100 : 380-384.
35. Dmochowski M, Hashimoto T, Chidgey MA, Yue KK, Wilkinson RW, Nishikawa T, Garrod DR (1995). Demonstration of antibodies to bovine desmocollin isoforms in certain pemphigus sera. Br J Dermatol. 133: 519-525.
36. Dobrev H, Popova L, Vlashev D (1996). Proteinase inhibitors and pemphigus vulgaris. An in vitro and in vivo study. Arch Dermatol Res. 288 : 648-655.
37. Dusek RL, Getsios S, Chen F, Park JK, Amargo EV, Cryns VL, Green KJ (2006). The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. J Biol Chem. 281 : 3614-3624.
38. Esaki C, Seishima M, Yamada T, Osada K, Kitajima Y (1995). Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol. 105 : 329-333.
39. Futei Y, Amagai M, Sekiguchi M, Nishifuji K, Fujii Y, Nishikawa T (2000). Use of domainswapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris. J Invest Dermatol. 115 : 829-834.
40. Gil MP, Modol T, Espa ñ a A, López-Zabalza MJ (2012). Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris. Exp Dermatol. 21 : 254-259.
41. Grando SA, Bystryn JC, Chernyavsky AI, Frusi p -Zlotkin M, Gniadecki R, Lotti R, Milner Y, Pittelkow MR, Pincelli C (2009). Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis. Exp Dermatol. 18 : 764-770.
42. Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM (2001). The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol. 144 : 775-780.
43. Hashimoto T, Ogawa MM, Konohana A, Nishikawa T (1990). Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol. 94 : 327-331.
44. Hertl M, Amagai M, Sundaram H, Stanley J, Ishii K, Katz SI (1998). Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. J Invest Dermatol. 110 : 62-66.
45. Ihrie RA, Marques MR, Nguyen BT, Horner JS, Papazoglu C, Bronson RT, Mills AA, Attardi LD (2005). Perp is a p63-regulated gene essential for epithelial integrity. Cell. 120: 843-856.
46. Jones JCR, Yokoo KM, Goldman RD (1986). Further analysis of pemphigus autoantibodies and their use in studies on the heterogeneity, structure and function of desmosomes. J Cell Biol. 102 : 1109-1117.
47. Kalinin AE, Kalinin AE, Aho M, Uitto J, Aho S (2005). Breaking the connection: caspase 6 disconnects intermediate fi lamentbinding domain of periplakin from its actin-binding N-terminal region. J Invest Dermatol. 124: 46-55.
48. Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, Shultz L, Murphy GF, Whitaker-Menezes D, Stanley JR (1997). Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol. 137 : 1091-1102.
49. Lanza A, Cirillo N, Femiano F, Gombos F (2006). How does acantholysis occur in pemphigus vulgaris: a critical review. J Cutan Pathol. 33 : 401-412.
50. Lanza A, Cirillo N (2007). Caspase-dependent cleavage of desmoglein 1 depends on the apoptotic stimulus. Br J Dermatol. 156: 400-402.
51. Lanza A, Cirillo N, Rossiello R, Rienzo M, Cutillo L, Casamassimi A, de Nigris F, Schiano C, Rossiello L, Femiano F, Gombos F, Napoli C (2008). Evidence of key role of Cdk2 overexpression in pemphigus vulgaris. J Biol Chem. 283 : 8736-8745.
52. Lanza A, Lanza M, Santoro R, Soro V, Prime SS, Cirillo N (2011). Deregulation of PERK in the autoimmune disease pemphigus vulgaris occurs via IgG-independent mechanisms. Br J Dermatol. 164 : 336-343.
53. Li N, Aoki V, Hans-Filho G, Rivitti EA, Diaz LA (2003). The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus(fogoselvagem). J Exp Med. 197 : 1501-1510.
54. Lin MS, Swartz SJ, Lopez A, Ding X, Fernandez-Vina MA, Stastny P, Fairley JA, Diaz LA (1997). Development and characterization of desmoglein-3 specifi c T cells from patients with pemphigus vulgaris. J Clin Invest. 99 : 31-40.
55. Mahoney MG, Wang ZH, Rothenberger K, Koch PJ, Amagai M, Stanley JR (1999a). Explanation for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest. 103 : 461-468.
56. Mahoney MG, Wang ZH, Stanley JR (1999b). Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J Invest Dermatol. 113 : 22-25.
57. Mascar ò JM, Espana A, Liu Z, Ding X, Swartz SJ, Fairley JA, Diaz LA (1997). Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence. Clin Imm Immunopat. 85 : 90-96.
58. Mao X, Nagler AR, Farber SA, Choi EJ, Jackson LH, Leiferman KM, Ishii N, Hashimoto T, Amagai M, Zone JJ, Payne AS (2010). Autoimmunity to desmocollin 3 in pemphigus vulgaris. Am J Pathol. 177: 2724-2730.
59. Nagasaka T, Nishifuji K, Ota T, Whittock NV, Amagai M (2004). Defi ning the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scaled skin syndrome. J Clin Invest. 114 : 1484-1492.
60. Nishifuji K, Amagai M, Kuwana M, Iwasaki T, Nishikawa T (2000). Detection of antigen-specifi c B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production. J Invest Dermatol. 114 : 88-94.
61. Osada K, Seishima M, Kitajima Y (1997). Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes. J Invest Dermatol. 108 : 482-487.
62. Patel HP, Diaz LA, Anhalt GJ, Labib RS, Takahashi Y (1984). Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. J Invest Dermatol. 83 : 409-415.
63. Pretel M, Espa ñ a A, Marquina M, Pelacho B, López-Picazo JM, L ó pez-Zabalza MJ (2009). An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris. Exp Dermatol. 18 : 771-780.
64. Puviani M, Marconi A, Cozzani E, Pincelli C (2003). Fas ligand in Pemphigus sera induces keratinocyte apoptosis through the activation of caspase 8. J Invest Dermatol. 120 : 164-167.
65. Rafei D, Müller R, Ishii N, Llamazares M, Hashimoto T, Hertl M, Eming R (2011). IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion. Am J Pathol. 178 : 718-723.
66. Rickman L, Simrak D, Stevens HP, Hunt DM, King IA, Bryant SP, Eady RA, Leigh IM, Arnemann J, Magee AI, Kelsell DP, Buxton RS (1999). N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantarkeratoderma. Hum Mol Genet. 8 : 971-976.
67. Schiltz JR, Michel B, Papay R (1979). Appearance of " pemphigus acantholysis factor " in human skin cultured with pemphigus antibody. J Invest Dermatol. 73 : 575-581.
68. Seishima M, Esaki C, Osada K, Mori S, Hashimoto T, Kitajima, Y (1995). Pemphigus IgG, but not bullous pemphigoidIgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol. 104 : 33-37.
69. Sekiguchi M, Futei Y, Fujii Y, Iwasaki T, Nishikawa T, Amagai M (2001). Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol. 167 : 5439-5448.
70. Shimizu A, Ishiko A, Ota T, Tsunoda K, Amagai M, Nishikawa T (2004). IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model. J Invest Dermatol. 122 : 1145-1153.
71. Shimizu A, Ishiko A, Ota T, Tsunoda K, Koyasu S, Amagai M, Nishikawa T (2002). Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris. Arch Dermatol Res. 294 : 318-323.
72. Shirakata Y, Amagai M, Hanakawa Y, Nishikawa T, Hashimoto K (1998). Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. J Invest Dermatol. 110 : 76-78.
73. Shu E, Yamamoto Y, Aoyama Y, Kitajima Y (2007). Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis. Arch Dermatol Res. 299 : 165-167.
74. Stanley JR, Year M, Hawley Nelson P, Katz SI (1982). Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest. 70 : 281-288.
75. Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, Huber O (2001). Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem. 276 : 4972-4980.
76. Tsunoda K, Ota T, Aoki M, Yamada T, Nagai T, Nakagawa T, Koyasu S, Nishikawa T, Amagai M (2003). Induction of pemphigus phenotype by a mousemonoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol. 170 : 2170-2178.
77. Veldman C, Stauber A, Wassmuth R, Uter W, Schuler G, Hertl M (2003). Dichotomy ofautoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles. J Immunol. 170 : 635-642.
78. Veldman C, H ö hne A, Dieckmann D, Schuler G, Hertl M (2004a). Type I regulatory T cells specifi c for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J Immunol. 172 : 6468-75.
79. Veldman CM, Gebhard KL, Uter W, Wassmuth R, Gr ö tzinger J, Schultz E, Hertl M (2004b). T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals. J Immunol. 172 : 3883-3892.
80. Wang X, Bregegere F, Frusic-Zlotkin M, Feinmesser M, Michel B, Milner Y (2004). Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosis. 9 : 131-143.
81. Waschke J, Bruggeman P, Baumgartner W, Zillikens D, Drenckhahn D (2005). Pemphigus foliaceusIgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction. J Clin Invest. 115 : 3157-3165.
82. Waschke J, Spindler V, Bruggeman P, Zillikens D, Schmidt G, Drenckhahn D (2006). Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol. 175 : 721-727.
83. Weiske J, Schoneberg T, Schroder W, Hatzfeld M, Tauber R, Huber O (2001). The fate of desmosomal proteins in apoptotic cells. J Biol Chem. 276 : 41175-41181.
84. Williamson L, Raess NA, Caldelari R, Zakher A, de Bruin A, Posthaus H, Bolli R, Hunziker T, Suter MM, Müller EJ (2006). Pemphigus vulgaris identifi es plakoglobin as key suppressor of c-Myc in the skin. EMBO J. 25 : 3298-3309.
85. Wolff K, Schreiner E (1971). Ultrastructural localization of pemphigus autoantibodies within the epidermis. Nature. 229 : 59-61.
86. Wucherpfennig KW, Yu B, Bhol K, Monos DS, Argyris E, Karr RW, Ahmed AR, Strominger JL (1995). Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci U S A. 92: 11935-11939.
87. Yamamoto Y, Aoyama Y, Shu E, Tsunoda K, Amagai M, Kitajima Y (2007). Antidesmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity. J Biol Chem. 282 : 17866-17876.